Amisulpride and Transferrin saturation decreased - a phase IV clinical study of FDA data

Summary:

Transferrin saturation decreased is reported as a side effect among people who take Amisulpride (amisulpride), especially for people who are female, 30-39 old, also take Valproic Acid, and have Dyspnea.

The phase IV clinical study analyzes which people have Transferrin saturation decreased when taking Amisulpride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Amisulpride from the FDA, and is updated regularly.

What is Amisulpride?

Amisulpride has active ingredients of amisulpride. eHealthMe is studying from 6,389 Amisulpride users. Check the latest studies of Amisulpride.

What is Transferrin saturation decreased?

Transferrin saturation decreased is found to be associated with 88 drugs and 228 conditions by eHealthMe. Check the latest studies of Transferrin saturation decreased.

On Jul, 09, 2026

6,364 people reported to have side effects when taking Amisulpride.
Among them, 13 people (0.2%) have Transferrin saturation decreased.

Could Amisulpride cause Transferrin saturation decreased?

Among these 13 people:

What is the gender of people who have Transferrin saturation decreased when taking Amisulpride? *

female: 100 %
male: 0.0 %

What is the age of people who have Transferrin saturation decreased when taking Amisulpride? *

What are other drugs people take besides Amisulpride? *

Mirtazapine: 13 people, 100.00%
Diazepam: 13 people, 100.00%
Furosemide: 13 people, 100.00%
Valproic Acid: 13 people, 100.00%
Topiramate: 10 people, 76.92%
Clozaril: 7 people, 53.85%
Metformin Hydrochloride: 7 people, 53.85%
Zopiclone: 6 people, 46.15%
Metformin: 6 people, 46.15%
Nicotine: 6 people, 46.15%

What are other side effects people have besides Transferrin saturation decreased? *

Troponin Increased: 13 people, 100.00%
Thyroxine Free Decreased: 13 people, 100.00%
Blood Alkaline Phosphatase Increased: 13 people, 100.00%
Blood Bilirubin Decreased: 13 people, 100.00%
Blood Glucose Increased: 13 people, 100.00%
Blood Phosphorus Increased: 13 people, 100.00%
Blood Prolactin Increased: 13 people, 100.00%
C-Reactive Protein Increased: 13 people, 100.00%
Haematocrit Decreased: 13 people, 100.00%
Haemoglobin Decreased: 13 people, 100.00%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 10 people, 76.92%
Dyspnea (difficult or laboured breathing): 10 people, 76.92%
Arrhythmias (irregular heartbeat): 9 people, 69.23%

* Approximation only. Some reports may have incomplete information.

Do you take Amisulpride and have Transferrin saturation decreased?

- Check whether Transferrin saturation decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amisulpride:

Amisulpride (6,389 reports)

Browse all side effects of Amisulpride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Transferrin saturation decreased:

Transferrin saturation decreased (88 drugs)

Browse all the conditions that are associated with Transferrin saturation decreased:

Transferrin saturation decreased (228 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amisulpride (the active ingredients of Amisulpride) and Amisulpride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.